atorvastatin

(redirected from Liptruzet)
Also found in: Thesaurus, Medical.

a·tor·va·stat·in

 (ə-tôr′və-stăt′n)
n.
A statin drug, C33H34FN2O5, that blocks the body's synthesis of cholesterol and is used in its hydrated calcium form to lower cholesterol (especially LDL) levels and to reduce the risk of heart attack and stroke in individuals with elevated risk.

[ator-, of unknown origin + -vastatin, statin suffix; see pravastatin.]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.atorvastatin - an oral drug (trade name Lipitor) that is effective in lowering triglyceridesatorvastatin - an oral drug (trade name Lipitor) that is effective in lowering triglycerides; potent in reducing LDL cholesterol because higher doses can be given
lipid-lowering medication, lipid-lowering medicine, statin, statin drug - a medicine that lowers blood cholesterol levels by inhibiting HMG-CoA reductase
Translations

atorvastatin

n atorvastatina
References in periodicals archive ?
* Cholib (simvastatin/fenofibrate; AbbVie): What are the key differences between Cholib's and Liptruzet's target patient populations?
Merck's pharmaceutical operations are ramping up their production capacity with the recent addition of Liptruzet cholesterol inhibiting tablets, being manufactured in Las Piedras, said Andrew Wirths, general manager of the company on the island, reports News Is My Business (May 30, 2013).
M2 EQUITYBITES-May 7, 2013-i" Merck receives FDA approval for Liptruzet tablets(C)2013 M2 COMMUNICATIONS http://www.m2.com
M2 PHARMA-May 7, 2013-i" Merck receives FDA approval for Liptruzet tablets(C)2013 M2 COMMUNICATIONS
In May 2013, FDA approved Liptruzet, a combination of Merck's Zetia and atorvastatin (generic Lipitor), to lower LDL cholesterol.
M2 EQUITYBITES-May 6, 2013-Merck's LIPTRUZET approved by US FDA(C)2013 M2 COMMUNICATIONS http://www.m2.com
M2 PHARMA-May 6, 2013-Merck's LIPTRUZET approved by US FDA(C)2013 M2 COMMUNICATIONS